Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial

NCATS Open Data2022-11-22 更新2026-08-08 收录

新冠病毒

疫苗免疫原性

数据链接：

https://doi.org/10.1101/2022.11.18.22282414 数据链接链接失效反馈

官方服务：

资源简介：

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial

创建时间：

2022-11-20

Immunogenicity and safety of a 4th homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a phase 2, randomized, placebo-controlled trial

资源简介：

相关数据集